Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Tables)

Common Stock (Tables)

3 Months Ended

Mar. 31, 2015

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Share-based Compensation, Activity

The following table summarizes the stock-based compensation expense from stock option awards, restricted common stock awards, employee stock purchase programs and warrants for the three months ended March 31, 2015 and 2014:

	For the three months ended March 31,
($ in thousands)	2015		2014
Employee awards	$	1,463	$	1,122
Non-employee awards		7		13
Total stock-based compensation expense	$	1,470	$	1,135

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes stock option activity:

	Outstanding Options						Weighted
($ in thousands except per share amounts)	Number of Shares		Weighted Average Exercise Price		Total Weighted Average Intrinsic Value		Average Remaining Contractual Life (in years)
Options vested and expected to vest at December 31, 2014		2,164,365	$	4.69	$			7.38
Options granted
Options exercised		(100,000)		2.15		170
Options cancelled
Options vested and expected to vest at March 31, 2015		2,064,365	$	4.82	$			7.20
Options vested and exercisable		1,681,032	$	4.58	$			7.00

Nonvested Restricted Stock Shares Activity

The following table summarizes restricted stock award and restricted stock unit activity:

	Restricted Stock
	Number of Shares		Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2014		8,287,384	$	2.33
Restricted stock granted		200,000		3.04
Restricted stock vested		(783,115)		2.43
Restricted stock units granted		61,000		2.34
Restricted stock units vested		(25,000)		2.19
Unvested balance at March 31, 2015		7,740,269	$	2.34